Arrowhead’s Gene-Silencing Drug Shows Promising Weight Loss Results
Arrowhead Pharmaceuticals announced promising early results from its gene-silencing drug, ARO-INHBE, which has demonstrated significant weight loss effects in individuals with obesity. In a Phase 1/2 study, patients receiving two…